Covid-19 Research

Letter to Editor

Recommendations for Individualized Rehabilitation of Syncope in Children and Adolescents during the COVID-19 Epidemic

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Letter to Editor
Subject Medicine Group
OCLC 8609419941
Xin Wang, Haihui Xiao, Yi Xu and Cheng Wang*
Issue: Volume1-Issue2
Pages: 021-023
Received: 2020-05-25
Accepted: 2020-06-12
Published: 2020-06-12

Abstract

Since December 2019, the outbreak of SARS-CoV-2 in WuHan, HuBei province, has spread to the whole country and abroad. As a susceptible population, the number of children and adolescents is increasing day by day. Under the severe situation of epidemic prevention and control, pediatric department has successively launched the expert consensus and treatment recommendations on the prevention and control of novel coronavirus pneumonia (COVID-19) in related fields. Syncope is a common emergency in children and adolescents, recurrent syncope seriously affects the quality of life and mental health of children. It is difficult for children with syncope to seek medical treatment during the epidemic period. This paper puts forward some Suggestions on the rehabilitation of children and adolescents with syncope during the epidemic period.

FullText HTML FullText PDF DOI: 10.37871/jels1115 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2020 Wang X, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Wang X, Xiao H, Xu Y, Wang C. Recommendations for Individualized Rehabilitation of Syncope in Children and Adolescents during the COVID-19 Epidemic. J Biomed Res Environ Sci. 2020 Jun 12; 1(2): 021-023. DOI: 10.37871/jels1115; Article ID: jels1115

Subject area(s)

Immunology

University/Institute

Central South University

References

  1. National Health Committee of the People’s Republic of China. Diagnosis and treatment plan of novel coronavirus pneumonia.
  2. Wang C, Li Y, Liao Y, Hong T, Min H, Xiangyu D, et al. 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents. Sci Bull. 2018; 63: 1558-1564. DOI:
  3. https://doi.org/10.1016/j.scib.2018.09.019
  4. Zhang Z, Jiang X, Han L, Selena C, Ling T, Chunyan T, et al. Differential diagnostic models between vasovagal syncope and psychogenic pseudosyncope in children. Front Neurol. 2020; 10: 1392. DOI: 10.3389/fneur.2019.01392
  5. Pediatric syncope professional committee of pediatrician branch of Chinese medical association, functional cardiovascular assistance group of cardiovascular group of pediatric branch of Chinese medical association, child cardiovascular professional committee of cardiovascular physician branch of Chinese medical association, et al. Suggestions on the implementation of head-up tilt test in children and adolescents with syncope during the COVID-19 epidemic. Chin J Appl Clin Pediatr. 2020; 35: 130-132.
  6. Accurate diagnosis and treatment of cardiomyopathy in children in the cardiology group of the pediatric society of Chinese medical association, Cardiology group heart failure cooperative group of Chinese pediatric society. Clinical management suggestions for children and adolescents with chronic heart failure in the prevention and control of new coronavirus pneumonia. Chin J Appl Clin Pediatr. 2020; 35: 112-117.
  7. Yogasundaram H, Hung W, Paterson ID, Consolato S, Gavin YO. Chloroquine-induced cardiomyopathy: A reversible cause of heart failure. ESC Heart Fail. 2018; 5: 372-375. DOI: 10.1002/ehf2.12276
  8. Yogasundaram H, Putko BN, Tien J, D Ian Paterson, Bibiana Cujec, Jennifer R, et al. Hydroxychloroquine-induced cardiomyopathy: Case report, pathophysiology, diagnosis, and treatment. Can J Cardiol. 2014; 30: 1706-1715. DOI: 10.1016/j.cjca.2014.08.016
  9. Kuba K, Imai Y, Rao S, Hong G, Feng G, Bin G, et al. A crucial role of Angiotensin Converting Enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005; 11: 875-879. DOI: 10.1038/nm1267
  10. Yan R, Zhang Y, Li Y, Lu Xia, Qiang Zhou. Structure of dimeric full-length human ACE2 in complex with B0AT1 [J/OL]. BioRxiv. DOI:
  11. https://doi.org/10.1101/2020.02.17.951848
  12. Ferrario CM, Jessup J, Chappell MC, David BA, Bridget KB, Tallant E Ann, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111: 2605-2610. DOI: 10.1161/CIRCULATIONAHA.104.510461
  13. Sun M, Yang J, Sun Y, Su GH. RAS inhibitors are one of the possible options for treating new coronavirus pneumonia. Chin J Tubere Respir Dis. 2020. DOI: 10.3760/cma.j.issn.1001-0939.2020.03.016
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership